SCHEMBL1436688

SCHEMBL1436688

CCOC(=O)c1ccc(-c2ccc(C=O)cc2)s1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.59
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
MAPT P10636 9/20 0.43
RAB9A P51151 9/20 0.43
NPC1 O15118 8/20 0.43
SMN1; SMN2 Q16637 7/20 0.43
ALDH1A1 P00352 7/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
HSD17B10 Q99714 4/20 0.43
GAA P10253 4/20 0.43
ALOX15 P16050 2/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 8/20 0.41
HPGD P15428 6/20 0.41
TP53 P04637 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1891576 0.87 ERN1 (0.57) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL12582258 0.85 ERN1 (0.54) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL18832290 0.84 PRF1 (0.54) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL1784438 0.84 ERN1 (0.56) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL4424903 0.84 ALDH1A1 (0.53) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL2715947 0.82 KDM4E (0.59) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL2028546 0.82 MAPT (0.62) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL1144728 0.82 IKBKB (0.58) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL12470090 0.82 ALDH1A1 (0.57) ERN1HDAC3HDAC4HDAC1HDAC6
SCHEMBL1891049 0.81 HDAC6 (0.55) ERN1HDAC3HDAC4HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7935724-B2 Thiophene and benzothiophene hydroxamic acid derivatives MERCK HDAC RESEARCH, LLC (US) 2011-05-03 US disclosed
US-7935724-B2 Thiophene and benzothiophene hydroxamic acid derivatives MERCK HDAC RESEARCH, LLC (US) 2011-05-03 US disclosed
US-7935724-B2 Thiophene and benzothiophene hydroxamic acid derivatives MERCK HDAC RESEARCH, LLC (US) 2011-05-03 US disclosed
WO-2011023791-A2 METHOD FOR PRODUCING ORGANOALUMINIUM COMPOUNDS AND USE THEREOF LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-03-03 WO disclosed
EP-1677731-A4 THIOPHENE AND BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES ATON PHARMA INC (US) 2009-05-06 EP disclosed
US-20070213392-A1 Thiophene and Benzothiophene Hydroxamic Acid Derivatives MERCK HDAC RESEARCH, LLC 2007-09-13 US disclosed
US-20070213392-A1 Thiophene and Benzothiophene Hydroxamic Acid Derivatives MERCK HDAC RESEARCH, LLC 2007-09-13 US disclosed
US-20070213392-A1 Thiophene and Benzothiophene Hydroxamic Acid Derivatives MERCK HDAC RESEARCH, LLC 2007-09-13 US disclosed
EP-1677731-A2 THIOPHENE AND BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES Aton Pharma, Inc. (US) 2006-07-12 EP disclosed
WO-2005034880-A2 THIOPHENE AND BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES ATON PHARMA, INC. (US) 2005-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213392-A1 Thiophene and Benzothiophene Hydroxamic Acid Derivatives BRDT, TXN, TXNRD2 ERN1 3676/4885HDAC3 27/4885HDAC4 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.